France on Saturday reported a lower daily toll for deaths from COVID-19, declaring a “plateau” had been reached in the country’s coronavirus epidemic, albeit at a very high level.
The French health authorities said in a statement that 345 more people had died in hospitals and 290 in nursing homes—635 over the last 24 hours—to bring the total death toll to 13,832.
The day earlier, 554 had died in hospitals and 433 in nursing homes, a total of 987.
“A very high plateau for the epidemic appears to have been reached but the epidemic remains very active,” top French health official Jerome Salomon told reporters. “We must absolutely remain vigilant.”
France has been in lockdown since March 17 in a bid to slow the spread of the epidemic, with only essential trips allowed that must be justified with a signed piece of paper.
For the third consecutive day, the number of coronavirus patients in intensive care was down, with 121 fewer people in such units for a total of 6,883.
France now has 90,676 confirmed cases of COVID-19 although the real number is likely far higher due to a lack of testing, the statement said.
Salomon said that if the plateau trend continues it means “we have succeeded in reaching a first step together and the lockdown is showing its first effects”.
But he warned: “It remains a very high plateau… there are still many hospital admissions… It is far too early—and not reasonable—to make predictions about the future.”
French President Emmanuel Macron is due on Monday to address the nation for a third time during the crisis and is expected to announce that the lockdown will be extended beyond its current April 15 expiration date.
Macron will have to steer a careful course amid the tentative signs of improvement, telling people they must still stay at home while giving indications about how the confinement may be relaxed.
Follow the latest news on the coronavirus (COVID-19) outbreak
© 2020 AFP
France reports fall in daily coronavirus deaths, toll tops 13,800 (2020, April 11)
retrieved 11 April 2020
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.
- COVID case rates hit new high for England, study finds - April 7, 2022
- Govt’s focus on affordable healthcare ensured significant savings for poor, middle class: PM Modi - April 7, 2022
- SRL Diagnostics and Skye Air Mobility collaborate to transport pathology samples using drone logistics - April 6, 2022
- Healthineers sets up new production line of CT scanners in Bengaluru under PLI scheme - April 6, 2022
- Lupin inks licensing pact with Alvion to market drugs in Southeast Asia - April 6, 2022
- Yoga Mahotsav: Ayush Ministry to organise event to demonstrate common yoga on World Health Day - April 6, 2022
- LordsMed forays into the medtech space with launch of health ATMs ‘Lords Sehat’ - April 5, 2022
- ‘Friendly viruses’ can be the next big thing in the history of medical research and more - April 5, 2022
- No setback to Bharat Biotech even as WHO suspends Covaxin UN supply: Sources - April 4, 2022
- Govt panel recommends Serum’s Covovax dose for kids aged 12 and above - April 4, 2022